Ropes & Gray advised medical device company Vapotherm Inc. in connection with a $56 million initial public offering. The company will use the proceeds on sales and marketing staff, expanding marketing programs and research and development. Shares debuted on the New York Stock Exchange on Nov. 14, trading under the symbol VAPO.
Vapotherm makes noninvasive breathing aids, sold primarily to hospitals, to treat respiratory distress including heart failure, chronic obstructive pulmonary disease, asthma and pneumonia.
The Ropes & Gray team was led by life sciences partners Steven Wilcox and Michael Beauvais and securities & public companies counsel Thomas Danielski (all of Boston). The team also included tax & benefits partners Renata Ferrari and Aaron Harsh, and health care partner Eve Brunts (all of Boston), and life sciences partner Albert Cacozza (Washington, D.C.).
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.